One of the goals of the new kidney allocation system implemented in December 2014 is to increase transplant opportunities for difficultto-match patients. Indeed, transplantation rates significantly increased for patients with calculated panel reactive antibody (cPRA) 99-100%, suggesting that more broadly sensitized recipients are receiving kidney transplants. 
Potential solid organ transplant recipients broadly sensitized to HLA have long wait times, low transplant rates and poor outcomes. The new kidney allocation system has improved access to the most highly sensitized recipients; however, their long-term outcomes are unknown. Emerging data suggest that memory B cell repertoire is broader than the plasma cell repertoire, therefore, despite refinements in anti-HLA antibody detection technology, donor-specific HLA-specific memory B cells may in fact be present in some, if not most, highly sensitized recipients with no detectable donor-specific antibodies. In addition, new findings have underscored the heterogeneity in memory B cell generation, and in the signals that determine memory versus plasma cell fate during primary antigen encounter, as well as memory B cell differentiation upon antigen reencounter into plasma cells or reentry into germinal centers to subsequently emerge as higher affinity and class-switched plasma cells. Thus, heterogeneity memory B cells generation may affect the efficacy of specific immunomodulation during the recall response. We propose that the ability to quantify donor-specific B cell in transplant recipients is urgently required to provide insights into the mechanisms of sensitization and recall, and for the early detection of acute and chronic AMR.
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alloantibody, B cell biology, basic (laboratory) research/science, editorial/personal viewpoint, immunobiology, plasma cells, rejection: antibody-mediated (ABMR) the plasma cell repertoire, 4 so that serological memory may not be equivalent to the memB repertoire. Interestingly, a relatively large retrospective study demonstrated that past high-sensitization status defined by either a cPRA (>50%) or peak-PRA (pPRA) (>50%) correlates with inferior graft outcomes, including increased incidence of delayed graft function, increased rejection rates, and decreased graft survival. 5 Furthermore, graft outcomes were inferior even in the low-sensitized group (PRA 5-50%) and in those that "converted" from a high-sensitized to low-sensitized group over time prior to transplantation. These observations raise the possibility that donorspecific memB may in fact be present in some, if not most, highly sensitized recipients of permissive donor allografts.
The diversity of the B cell repertoire supports the hypothesis that high cPRA is product of a broad repertoire of plasma cells producing antibodies that recognize specific HLA alleles or shared eplets. 6, 7 The universality of this notion has, however, been challenged by the series of publications by Zorn and colleagues, [8] [9] [10] [11] [12] that anti-HLA serum reactivity may comprise, at least in part, polyreactive antibodies. Thus, it is possible that high cPRA may be explained by polyreactive antibodies produced by a limited repertoire of plasma cells. These antibodies may bind to antigens exposed on apoptotic cells or to denatured antigens on single HLA antigen beads used to detect HLA-specific antibodies. 8, 10 Furthermore, these polyreactive antibodies, similar to HLA-specific antibodies, can activate complement to cause cell injury, 10 and potentially, promote the generation of opsonins that enhance antigen uptake and presentation to donorspecific T and B cells 13, 14 or mediate the recruitment Fc-expressing cells that elicit graft injury. [15] [16] [17] [18] The potential role of polyreactive antibodies in solid organ transplantation has recently been reviewed 11 and will not be discussed further; instead, we focus on discussing the latest findings on the heterogeneity in memB cells mediating the recall humoral response ( Figure 1 ) and potential implications to solid organ transplantation.
| How naïve B cells differentiate into antibody secreting cells and memory B Cells
The progression of a naïve B cell into a memory and plasma cells fate. 33, 34 In contrast, more modest levels of IRF4 are required for differentiation into GC B cells. 31, 33 In the late GC-dependent phase, the generation of plasma cells is also dependent on their affinity for antigen presented on FDCs, and cognate interactions with Tfh. 24, 30 Kräutler et al 35 and therefore failed to enter the DZ were more likely to enter the memory compartment, suggesting that T cell help may be sufficient to drive memory differentiation without further proliferation or SMH that is necessary for PC differentiation. 42 Despite these new insights, the full spectrum of signals that control the post-GC memB cell fate decision and their exit from the GC remains unclear, and their full definition is hampered by the lack of a "master" transcription factor that can be used to trace these cells in vivo (reviewed previously 43 ). 45 showed that memB cells are generated mostly in the pre-GC and early GC pe- 
| Heterogeneity of the memory B cell recall response
Faster, higher-titer, and class-switched antibody production are hallmarks of a recall response upon reencounter with antigen.
Heterogeneity in memB cell generation suggests that these B cells The phenotype memB that predicts PC or GC fate has been further refined by recent studies. Shlomchik and colleagues 39, 45, 47, 48 reported that irrespective of IgM or IgG expression, memB cells that express CD80, PD-L2, and CD73 were mostly likely to produce PC, while those that lack these markers were more likely to Challenge with malaria-infected erythrocytes resulted in the early (d3) proliferation of high-affinity IgM + memB cells and differentiation into PC in both a T cell-dependent and independent manner.
Notably, the more highly mutated IgM + memory that responded to secondary challenge expressed CD80 and CD73 expression. Circulating memory Tfh promoted more secondary germinal centers, whereas the resident memory Tfh cells that localized close to memB cells in the B cell follicle promoted plasma cell differentiation. Those variables in turn dictated the kinetics of antibody production in the recall, and also the functional properties of the secreted antibodies.
| CON CLUS ION
How do these basic findings on heterogeneity of memB cells impact our understanding of the antibody response in sensitized patients after transplantation? When incompatible allografts are transplanted into recipients with preexisting DSA, it is reasonable to assume that they will also harbor donor-specific memB and memory T cells. whereas a recall response that is dependent on GC output may additionally be responsive to drugs that inhibit the GC response. In addition, the notion that memB cells have different longevity depending on the mutation load suggests that recently sensitized recipients may mount a recall DSA response that has a more rapid kinetics and higher affinity, whereas when the sensitizing event occurred many decades ago, a functional recall response may require reentry into a GC response and thus be more sensitive to immunosuppression that prevents the reactivation of Tfh and lower-affinity memB cells. antigens can be detected in the blood, and that their frequency tracks with time post-antigen exposure, 60, 61 suggest that an assay that accurately quantifies circulating donor-specific memB cells is feasible. 46, 62 Such an assay will likely complement our ability to quantify DSA by providing an earlier diagnosis of acute or chronic AMR, as well as in identifying successful desensitization protocols and treatments of AMR.
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